![Priya Singhal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Priya Singhal
Corporate Officer/Principal presso
BIOGEN INC.
Patrimonio netto: 2 M $ in data 31/05/2026
Profilo
Priya Singhal is currently Executive Vice President & Head-Development at Biogen, Inc. since 2021.
Formerly, Dr. Singhal was Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012, VP-Clinical Trials Benefit Risk Management at Biogen, Inc. from 2012 to 2018, and Head-Research & Development at Zafgen, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Mumbai and graduate studies at Harvard T.H.
Chan School of Public Health.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
BIOGEN INC. 0,01% | 21/04/2026 | 8.043 ( 0,01% ) | 2 M $ | 31/05/2026 |
Posizioni attive di Priya Singhal
| Società | Posizione | Inizio |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Priya Singhal
| Società | Posizione | Fine |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2018 |
| VERTEX PHARMACEUTICALS INCORPORATED | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
Formazione di Priya Singhal
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
78
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
